Novartis AG (NYSE:NVS) is one of the most profitable NYSE stocks to buy right now. HSBC lifted the price target on Novartis AG (NYSE:NVS) to $112 from$106 on December 10 while maintaining a Reduce rating on the shares. Novartis AG (NVS): Jim Cramer Wonders Whether Its CEO Is Leaving The rating update came as part of the 2026 outlook for the pharma group, with the firm telling investors that it sees the sector as well-positioned to outperform in the coming year. This trend is expected to materialize “eve ...